Latest News
SWEN Capital Partners, a specialist sustainable private equity, is offering privileged access to the infrastructure asset class, generally reserved for institutional investors, with the launch of SWEN Exclusive Infrastructures.
Investments firm MSD Partners is to make a strategic investment in North American digital consulting firm West Monroe.
Chairman & CEO Kevin McCarty and the rest of West Monroe’s senior management team will continue to lead the company following MSD’s investment.
West Monroe is a digital consulting firm with eight US offices and 2,000 employees across the globe. Established in 2002, the firm has grown revenue at a 30 per cent CAGR, outpacing the 10 per cent to 12 per cent average annual growth rate for consulting firms broadly.
MSD Partners pursues majority and strategic equity investments in situations where
PGIM Private Capital provided a USD65.0 million Senior Secured Credit Facility consisting of a USD50.0 million Senior Secured First Lien Term Loan and a USD15.0 million committed Delayed Draw Term Loan to ED&F Man Capital Markets US Holdings, Inc, a global financial brokerage business.
“We are pleased to provide funding to ED&F Man Capital Markets to provide strategic financing for the business as they pursue the next phase of growth. Our experience with similar financings in this sector introduced us to the opportunity to work with the Firm’s management team, forming a strong, direct partnership. Our relationship-oriented approach is reflected
Main Capital Partners (Main) has successfully completed the sale of financial software provider b+m Group to German technology investor LEA Partners, representing its first divestment in the DACH region.
Main Capital initially acquired b+m from publicly listed Allgeier SE in 2015. During their six year partnership, Main and b+m have successfully more than tripled recurring revenues, while also significantly increasing profitability. The b+m team has also expanded from approximately 90 to nearly 150 employees over the period.
Headquartered near Kiel in Germany, b+m Group develops software solutions for banks and insurance companies as a full-service provider of innovative products to
Buyout specialist Kester Capital (Kester), has invested in Rephine, a provider of Good Manufacturing/Clinical Practice (GMP/GCP) audits and regulatory consulting services to the pharmaceutical industry.
The investment represents Kester’s fourth investment in the Life Sciences sector, and the fourth investment out of its latest fund, Kester Capital II, which closed at its hard cap in August 2020. It also comes at a time of significant positive momentum for Kester, which recently exited Frontier Medical (netting a 3.4x return for its investors), completed two bolt-on acquisitions, and made two hires into its investment team.
Headquartered in Stevenage, and with offices
Global Healthcare Exchange (GHX) has acquired Chicago-based Explorer Surgical Corp, operator of a comprehensive digital and remote case support platform that connects suppliers with healthcare provider teams.
By combining Explorer Surgical’s digital expertise in creating innovative procedure playbooks, tele-mentoring and performance tracking tools with GHX’s cloud-based supply chain network and industry-leading collection of data and clinical evidence, the combined organisation will help providers and suppliers deliver a higher quality standard for patient care. Explorer Surgical will operate as a wholly owned subsidiary of GHX.
“To succeed in value-based healthcare, organisations must democratise knowledge and data to create more efficient
Colorcon, a specialist in pharmaceutical film coatings and specialty excipients, has acquired a majority share in Ideal Cures, a manufacturer of excipients and ready-to-use coating systems for solid oral dosage forms located in India.
The acquisition of Ideal Cures underscores the importance of India in the pharmaceutical sector by providing an expanded service network of manufacturing and technical capabilities, especially for the remotely located economic zones in North India.
Ideal Cures will operate as a fully independent entity within Colorcon. Their business complements Colorcon’s position in the Indian pharmaceutical market with a strong presence in the domestic generic
Citizens M&A Advisory has served as the exclusive financial advisor to Eclipse Advantage, a provider of outsourced supply chain workforce solutions, on its acquisition by Two Sigma Impact.
Eclipse provides a comprehensive suite of labour services for warehouses and distribution centres that increase supply chain productivity and efficiency. Eclipse was a portfolio company of Longshore Capital Partners, a Chicago-based lower middle-market private equity firm. Two Sigma Impact is the impact investing business of Two Sigma.
Pete Westermann, chief executive officer of Eclipse, says: “The Citizens M&A Advisory team was terrific to work with. Citizens assisted us in articulating our complex
BGF has appointed industry veteran Nicol Fraser to lead its investment team in London and the South East.
Fraser joins from private equity firm Dunedin where he was a partner in the business. Nicol led the investment team, investing across a broad range of sectors, with a particular specialism in technology enabled business and financial services.
In his 20-year career at Dunedin, Fraser helped to support management buy-outs and invested growth capital for companies with enterprise values of between GBP20 million to GBP100 million.
Prior to Dunedin, Fraser worked for private equity house Bridgepoint. He started his career at Tenon
Arctos Sports Partners (Arctos), a private investment platform dedicated to providing growth capital and liquidity solutions to professional sports franchise owners in major North American leagues and European soccer, has raised more than USD2.1 billion for its first flagship fund.
The fund complex, Arctos Sports Partners Fund I, along with co-investors and parallel affiliated vehicles, closed with more than USD3.0 billion in Regulatory Assets Under Management from a large, diverse group of global institutional investors. Arctos, which launched in April 2020, has already closed 14 investments into the fund, including ownership stakes in Fenway Sports Group, the Golden State Warriors
Special Reports
Featured
- Insight
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
